Mentioned:
A publicly traded company on the Nasdaq is shipping psilocybin to the United Kingdom. But, why?
What’s happening:
- Optimi Health (NASDAQ: OPTH) has successfully exported naturally derived psilocybin to the United Kingdom to support a Phase II clinical trial
Why it matters:
- This is the first naturally derived psilocybin shipment Optimi Health has ever made to the United Kingdom
Going deeper:
- Optimi Health has publicly stated that their shipment of naturally derived psilocybin contains both psilocybin biomass and finished 5 milligram psilocybin capsules
- All of the psilocybin products exported by Optimi Health were manufactured at their GMP facility located in Princeton, British Columbia and were shipped in compliance with Health Canada regulations
The fine print:
- It has not yet been publicly disclosed what clinical trial Optimi Health’s psilocybin products are being used in
